Refractory right ventricular myocarditis induced by immune checkpoint inhibitor despite therapy cessation and immune suppression

BACKGROUND: Immune checkpoint inhibitors (ICIs) are currently widely used for treatment of various types of cancers. ICI-induced myocarditis, though uncommon, accounts for high risk of major adverse cardiac events and mortality, which makes appropriate diagnosis important. We here present a unique,...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammad, Khan O., Fanous, Hanna, Vakamudi, Sneha, Liu, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026228/
https://www.ncbi.nlm.nih.gov/pubmed/36941689
http://dx.doi.org/10.1186/s40959-023-00165-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026228/
https://www.ncbi.nlm.nih.gov/pubmed/36941689
http://dx.doi.org/10.1186/s40959-023-00165-2

Ejemplares similares